Debio-0932 (CUDC305)

CAS 1061318-81-7 MFCD161318817

化学结构图

1061318-81-7
SMILES: CNc1nccc(-c2ncc(C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl)s2)n1

化学属性

Mol. Weight442.5776
Appearance white to off-white solid powder
SolubilitySoluble in DMSO, not in water

别名和识别编码

Chemical NameDebio-0932 (CUDC305)
FormulaC22H30N6O2S
Synonym Debio0932; Debio-0932; Debio 0932; CUDC305; CUDC-305; CUDC 305.
IUPAC Name2-((6-(dimethylamino)benzo[d][1,3]dioxol-5-yl)thio)-1-(2-(neopentylamino)ethyl)-1H-imidazo[4,5-c]pyridin-4-amine
InChIKeyPFYLLYYLCPZDMP-LBPRGKRZSA-N
InChIInChI=1S/C18H18Cl2N6OS/c1-22-18-23-5-4-14(26-18)17-24-9-15(28-17)16(27)25-12(8-21)6-10-2-3-11(19)7-13(10)20/h2-5,7,9,12H,6,8,21H2,1H3,(H,25,27)(H,22,23,26)/t12-/m0/s1
Canonical SMILESO=C(C1=CN=C(C2=NC(NC)=NC=C2)S1)N[C@@H](CC3=CC=C(Cl)C=C3Cl)CN
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

产品应用

  • Debio 0932, also known as CUDC-305, is a novel heat shock protein 90 (HSP90) inhibitor with strong affinity for HSP90 alpha/beta, high oral bioavailability and potent anti-proliferative activity against a broad range of cancer cell lines (with a mean IC50 of 220 nmol/L), including many non-small cell lung cancer (NSCLC) cell lines which are resistant to standard-of-care (SOC) agents. Debio 0932 potently inhibits tumour growth in subcutaneous xenograft models of a number of solid and haematological malignancies, including models of NSCLC which harbour mutations conferring acquired or primary erlotinib resistance.

安全信息

Storage condition Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

系列性分类


相关产品推荐